Print this page    •   Back to Web version of article

Fact Sheet

Bangkok Tenofovir Study: PrEP for HIV Prevention Among People Who Inject Drugs

June 12, 2013

Summary


Trial Design and Study Population

Advertisement


Study Results

Efficacy


Adherence


Risk Behavior


Safety and Resistance


Retention


Reference

Choopanya K. et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomized, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381:2083-90.




This article was provided by U.S. Centers for Disease Control and Prevention. You can find this article online by typing this address into your Web browser:
http://www.thebodypro.com/content/71803/bangkok-tenofovir-study-prep-for-hiv-prevention-am.html

General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.